The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.
申请公布号
WO2007059221(A9)
申请公布日期
2007.08.23
申请号
WO2006US44363
申请日期
2006.11.13
申请人
VERTEX PHARMACEUTICALS, INC;LIN, CHAO;KIEFFER, TARA;SARRAZIN, CHRISTOPH;KWONG, ANN
发明人
LIN, CHAO;KIEFFER, TARA;SARRAZIN, CHRISTOPH;KWONG, ANN